Getting personal with cancer
18 June, 2014 by Tim DeanRecent work on developing targeted treatments for pancreatic cancer is paving the way for new approaches in personalised medicine.
Eucalyptus genome sequenced
13 June, 2014Initial results of the Eucalyptus genome sequence have been revealed.
Genetic Technologies hires new CFO
11 June, 2014Genetic Technologies' (ASX:GTG) new CFO, Eutillio Buccilli, has more than 35 years of senior management experience.
Reconfiguring the link between GAD65 and diabetes
11 June, 2014Another step has been taken in understanding the link between glutamic acid decarboxylase and type 1 diabetes.
DNA analysis on the go
04 June, 2014A mobile app that analyses DNA sequences has been developed and made freely available by researchers in Singapore.
GM farmer wins landmark court case
29 May, 2014The Supreme Court of Western Australia has dismissed the Marsh v Baxter case involving organic and conventional farming practices.
Gene therapy on trial for eye disease
20 May, 2014Positive results in initial trails suggest gene therapy could treat a common cause of blindness.
Haplomic Technologies nabs EU, US patents
28 April, 2014 by Dylan Bushell-EmblingHaplomic Technologies has picked up patents in the EU and the US for its core IP, which covers genetic sequencing technologies based on haplotypes.
New genes found on Y chromosomes
28 April, 2014A comparison of Y chromosome sequences across various mammals has revealed new gene repertoires for the major groups.
UQ gene researcher joins Illumina
23 April, 2014 by Dylan Bushell-EmblingUQ researcher Dr Ryan Taft has joined Illumina as director of scientific research, to help further the company's work on using the human genome to identify disease-carrying mutations.
Fast-paced evolution of proteins
02 April, 2014Researchers have uncovered a new family of seed proteins as well as provided an explanation for 'de novo protein evolution'.
E. coli strain nears complete resistance
02 April, 2014Genome sequencing of a multidrug-resistant Escherichia coli strain has revealed this bacterium is close to becoming resistant to almost all antibiotics.
GTG reaches settlement deal with Promega
26 March, 2014 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has reached a deal to license its genomic mapping patents to US-based Promega Corporation.
Integrating genetics and genomics into health care
13 February, 2014The Melbourne Genomics Health Alliance, comprising seven organisations, has been launched at The Royal Children's Hospital.
Enzymes with alter egos
12 February, 2014 by Graeme O'NeillEnzymes are well known for their housekeeping role in cells, but some enzymes bind RNA and might play a significant role in linking intermediary metabolism to gene expression via post-transcriptional regulation.
